merrion street

Taoiseach Enda Kenny today announced that Pfizer, the world’s leading Biopharmaceutical Company, is to make a substantial investment of $200 million (€145m) at its Grange Castle biotechnology manufacturing facility in Clondalkin, Co. Dublin.

Making today’s announcement, Taoiseach Enda Kenny said:

This is very welcome news by the leading Biopharmaceutical Company in the world. Pfizer has made a tremendous contribution to Ireland’s Life Sciences industry since it first established here in 1969 and this investment is a further demonstration of the company’s continuous commitment to Ireland.

Pfizer is one of Ireland’s leading employers and the largest pharmaceutical investor. One of the first pharmaceutical companies to locate in Ireland (1969), Pfizer has a rich heritage of innovation and expression over a forty yea r period. The business has approx 4,300 colleagues across eight locations based in Cork, Dublin, Kildare and Limerick.

The investment will enable Pfizer to introduce two new processing suites to the site and expand current production and product testing capabilities. This investment has resulted in the generation of significant construction employment (up to 400 jobs) during peak construction periods.

Pfizer’s Grange Castle facility is one of the largest biotech manufacturing sites in the world and currently produces two of the company’s blockbuster medicines – Enbrel and Prevenar 13. The Grange Castle facility is strategically important to Pfizer globally. Since opening in 2005, it has evolved into a highly specialised site for manufacturing, testing and developing medicines for patients around the world. The site currently employs approximately 1100 full time staff.